StonvexLoading…
StonvexStonvexStonvexCore line items from DXCM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.66B | $4.03B | $3.62B | $2.91B |
Operating Income | $911.80M | $600.00M | $597.70M | $391.20M |
Net Income | $836.30M | $576.20M | $541.50M | $341.20M |
EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 |
Total Assets | $6.34B | $6.48B | $6.26B | $5.39B |
Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B |
Cash & Equivalents | $917.70M | $606.10M | $566.30M | $642.30M |
Free Cash Flow OCF − CapEx | $1.08B | $630.70M | $511.90M | $304.70M |
Shares Outstanding | 384.80M | 390.70M | 385.40M | 386.30M |